Drug intelligence / Profile preview

BSL_EP028

Development stage
Preclinical
Lead developer
Global Preventive Medicine Biotech
Administration
Oral
01

Overview

BSL_EP028 is a combination product comprised of multiple plant extracts, marketed under the brand name Dibifree. It is investigated primarily for its potential in improving joint mobility, physical performance, and vitality, as well as for regulating blood sugar and hemoglobin A1c in patients with type 2 diabetes. The product contains the following ingredients: bitter melon (Momordica charantia) fruit extract, celery (Apium graveolens) seed extract, baker's yeast (Saccharomyces cerevisiae) cell wall extract, acerola (Malpighia emarginata) fruit extract, grape (Vitis vinifera) seed extract, green tea leaf extract, and hydrolyzed soy protein powder. The exact mechanism of action is not fully characterized, and its therapeutic activity is attributed to the combined effects of these bioactive plant-derived compounds, which are hypothesized to possess antioxidant, anti-inflammatory, and metabolic-modulating properties[3][5][1][7].

Brand names
Dibifree
Other names
BSL_EP028 Dibifree

Beyond the preview

Go deeper on BSL_EP028.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BSL_EP028.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call